Mixed options sentiment in Novo Nordisk (NVO), with shares down 6c near $52.90. Options volume roughly in line with average with 80k contracts traded and calls leading puts for a put/call ratio of 0.76, compared to a typical level near 0.65. Implied volatility (IV30) is higher by 0.9 points near 59.49, in the highest 10% of observations over the past year, suggesting an expected daily move of $1.98. Put-call skew steepened, indicating increased demand for downside protection.Looking ahead: Novo Nordisk (NVO) will report earnings before the open on 2025-11-05.Option markets are pricing in a 50% probability of a move greater than 8.87% or $4.69.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Novo Nordisk’s Real-World Study on Wegovy: A Potential Game Changer in Obesity Management
- Novo Nordisk’s DuraTouch® Study: Enhancing Diabetes Management
- Novo Nordisk’s Real-World Study on Semaglutide: Implications for Obesity Management
- Novo Nordisk’s Wegovy® Study: A Closer Look at Real-world Obesity Treatment
- Novo Nordisk’s New Study on Insulin Icodec: Implications for Diabetes Care and Market Impact